Can serum biomarkers predict the outcome of systemic immunosuppressive therapy in adult atopic dermatitis patients?

07 Jan 2022·
Guillem Hurault
Guillem Hurault
,
E. Roekevisch
,
M.E. Schram
,
K. Szegedi
,
S. Kezic
,
M.A. Middelkamp-Hup
,
P.I. Spuls
,
R.J. Tanaka
· 0 min read
Type
Publication
Skin Health and Disease, 2(1), e77
publications
Guillem Hurault
Authors
Senior Data Scientist

I build probabilistic models of noisy real-world systems to improve decision making. Right now that means forecasting the outcome of sports events; previously it was electricity demand and prices, and before that the progression of eczema severity in patients.

In particular, I developed expertise in Bayesian modelling, time-series forecasting, and decision analysis. I am also interested in the engineering around models, in order to deploy reproducible, maintainable, and well-tested solutions in production.